Continental Investors Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Continental Investors Services's ABBV Position: Q2 2026 in Review
Continental Investors Services increased its AbbVie (ABBV) stake by 5% in Q2 2026, buying an estimated $48.8K and bringing the position to 4,727 shares worth $1.16M. The position accounts for 0.91% of the portfolio, ranked #23.
Continental Investors Services first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Continental Investors Services held 4,727 shares of AbbVie worth $1.16M as of Q2 2026.
- Continental Investors Services bought 227 AbbVie shares in Q2 2026, an estimated $48.8K.
- AbbVie made up 0.91% of Continental Investors Services's portfolio in Q2 2026, its #23 holding.
- Continental Investors Services first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Continental Investors Services's 13F filing for Q2 2026, filed 13 Aug 2026.